Continuation Study for Patients Benefiting from ZEN003694 Treatment

Sponsor: Zenith Epigenetics

Sponsor score: 0

ClinicalTrials ID:NCT04145375

This study allows patients who have been benefiting from the drug ZEN003694 in a previous trial to continue receiving the treatment. It is designed for those who have completed their initial study and are still experiencing positive effects from the medication.

Patient Parameters

Program Overview

This study is for patients who have been taking the drug ZEN003694 in a previous clinical trial and have shown positive results. If you have completed your initial trial and your doctor believes you are benefiting from the treatment, you can continue to receive ZEN003694 in this follow-up study. This continuation study is open to those who were part of a Zenith Epigenetics-sponsored trial.

Description

This study is open to patients who have completed a previous trial with the drug ZEN003694 and are experiencing benefits from it. The study is not randomized, meaning all participants will receive the same treatment. To join, you must have been part of a previous ZEN003694 study and shown improvement as judged by your doctor. The study aims to continue providing the drug to those who are benefiting from it.

Eligibility Criteria

Inclusion Criteria

  • Completed a previous ZEN003694 trial as defined by the study protocol.
  • Showing clinical benefits from the treatment, as determined by your doctor.
  • Have a performance status score of 0 or 1, indicating full activity or some restriction in strenuous activities.
  • Tolerating ZEN003694 well, according to your doctor's judgment.
  • Start the continuation study within two weeks of finishing the previous trial, unless more time is approved.

Exclusion Criteria

  • Participating in another clinical trial for a different treatment.
  • Need to start or change another treatment to manage your cancer.
  • Stopped taking ZEN003694 or withdrew from the original study.
  • Any other reason your doctor believes would prevent you from completing the study or following the schedule.

Locations

FACILITYZIPCITYSTATE
University of California San Francisco Medical Center94104San FranciscoCalifornia
Oregon Health & Science University97239PortlandOregon

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.